Mechanistic Modeling and Virtual Trials Inform Prostate Cancer Radiopharmaceutical Dosing Schedules
A mechanistic mathematical model and in silico trials identified key dosing trade-offs to help personalize radiopharmaceutical therapy for metastatic prostate ...






